If you are interested in getting in touch, contact Madeleine Walters at firstname.lastname@example.org or email@example.comPosted by Emily Kibble on December 2nd, 2019
By Dr Gregor Ferguson
The 2016 Defence White Paper was significant for a number of reasons but for Dr Felicia Pradera, Program Manager Medical Countermeasures within DST’s Land Division at Fishermans Bend it was ground-breaking. For the first time its inclusion reflected both an official acknowledgement that medical countermeasures were a critical defence requirement, and funding from the Next Generation- Technology Fund (NGTF) would be allocated to develop this national capability.
Medical countermeasures (MCM) are vaccines, therapeutics and diagnostics against Chemical, Biological and Radiological (CBR) threats, emerging infectious diseases and pandemics. It has been said that a CBR threat does not care whether you are wearing a military uniform or not. Therefore MCMs have relevance to both civilian and military personnel making it a national security issue. (more…)Posted by Emily Kibble on November 1st, 2019 Tagged: CBR Threats, collaboration, CSIRO, DMTC, DST Group, ISO accreditation, MCM, Medical Countermeasures, NGTF
By Mr Harry Baxter
A DMTC project team leading advances in the development of a field-deployable, handheld Point of Care diagnostic device has been honoured with a National Innovation Award in the Combat Equipment and Mobility category at the international Land Forces 2018 Exposition.
The project involves industry partners Lumos Diagnostics, a wholly-owned subsidiary of Victorian medical technology firm Planet Innovation, and Queensland-based Anteo Technologies with support from research partner Deakin University. (more…)Posted by Emily Kibble on November 1st, 2019 Tagged: DMTC, Lumos Diagnostics, MCM, National Innovation Award, Point of Care, Rapid Diagnostic
By Dr Felicia Pradera and Ms Madeleine Walters
Whether Australia is adequately prepared for a future pandemic should be a key issue on our national agenda. Over the past few years, antimicrobial resistance has become an area of growing concern for our health security. According to the OECD, Australia is particularly vulnerable as our antibiotic usage is significantly higher than the organisation’s average.
The OECD has estimated that nearly 10% of infections in Australia are antimicrobial resistant and that an average of 290 people die each year due to multidrug-resistant bacterial infections. It forecasts that this number is likely to grow significantly in coming years. (more…)Posted by Emily Kibble on October 31st, 2019 Tagged: AMR, antimicrobial resistance, collaboration, DMTC, MCM, Medical Countermeasures, pandemic